Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2016

01-02-2016 | Health Policy

The Roles of Cost and Quality Information in Medicare Advantage Plan Enrollment Decisions: an Observational Study

Authors: Rachel O. Reid, MD, MS, Partha Deb, PhD, Benjamin L. Howell, PhD, Patrick H. Conway, MD, MSc, William H. Shrank, MD, MSHS

Published in: Journal of General Internal Medicine | Issue 2/2016

Login to get access

ABSTRACT

BACKGROUND

To facilitate informed decision-making in the Medicare Advantage marketplace, the Centers for Medicare & Medicaid Services publishes plan information on the Medicare Plan Finder website, including costs, benefits, and star ratings reflecting quality. Little is known about how beneficiaries weigh costs versus quality in enrollment decisions.

OBJECTIVE

We aimed to assess associations between publicly reported Medicare Advantage plan attributes (i.e., costs, quality, and benefits) and brand market share and beneficiaries’ enrollment decisions.

DESIGN, SETTING, PARTICIPANTS

We performed a nationwide, beneficiary-level cross-sectional analysis of 847,069 beneficiaries enrolling in Medicare Advantage for the first time in 2011.

MAIN MEASURES

Matching beneficiaries with their plan choice sets, we used conditional logistic regression to estimate associations between plan attributes and enrollment to assess the proportion of enrollment variation explained by plan attributes and willingness to pay for quality.

KEY RESULTS

Relative to the total variation explained by the model, the variation in plan choice explained by premiums (25.7 %) and out-of-pocket costs (11.6 %) together explained nearly three times as much as quality ratings (13.6 %), but brand market share explained the most variation (35.3 %). Further, while beneficiaries were willing to pay more in total annual combined premiums and out-of-pocket costs for higher-rated plans (from $4,154.93 for 2.5-star plans to $5,698.66 for 5-star plans), increases in willingness to pay diminished at higher ratings, from $549.27 (95 %CI: $541.10, $557.44) for a rating increase from 2.5 to 3 stars to $68.22 (95 %CI: $61.44, $75.01) for an increase from 4.5 to 5 stars. Willingness to pay varied among subgroups: beneficiaries aged 64-65 years were more willing to pay for higher-rated plans, while black and rural beneficiaries were less willing to pay for higher-rated plans.

CONCLUSIONS

While beneficiaries prefer higher-quality and lower-cost Medicare Advantage plans, marginal utility for quality diminishes at higher star ratings, and their decisions are strongly associated with plans’ brand market share.
Appendix
Available only for authorised users
Literature
2.
go back to reference Jacobson GA, Neuman P, Damico A. At least half of new medicare advantage enrollees had switched from traditional medicare during 2006–11. Health Aff. 2015;34(1):48–55.CrossRef Jacobson GA, Neuman P, Damico A. At least half of new medicare advantage enrollees had switched from traditional medicare during 2006–11. Health Aff. 2015;34(1):48–55.CrossRef
7.
go back to reference Kolstad JT, Chernew ME. Quality and consumer decision making in the market for health insurance and health care services. Med Care Res Rev. 2009;66(1 suppl):28S–52S.CrossRefPubMed Kolstad JT, Chernew ME. Quality and consumer decision making in the market for health insurance and health care services. Med Care Res Rev. 2009;66(1 suppl):28S–52S.CrossRefPubMed
8.
go back to reference Dafny L, Dranove D. Do report cards tell consumers anything they don’t already know? The case of medicare HMOs. Natl Bur Econ Res Work Pap Ser. 2008;39(3):790–821. Dafny L, Dranove D. Do report cards tell consumers anything they don’t already know? The case of medicare HMOs. Natl Bur Econ Res Work Pap Ser. 2008;39(3):790–821.
10.
go back to reference McWilliams JM, Afendulis CC, McGuire TG, Landon BE. Complex Medicare advantage choices may overwhelm seniors—especially those with impaired decision making. Health Aff (Project Hope). 2011;30(9):1786–1794.CrossRef McWilliams JM, Afendulis CC, McGuire TG, Landon BE. Complex Medicare advantage choices may overwhelm seniors—especially those with impaired decision making. Health Aff (Project Hope). 2011;30(9):1786–1794.CrossRef
11.
go back to reference Kuye IO, Frank RG, McWilliams JM. Cognition and take-up of subsidized drug benefits by medicare beneficiaries take-up of drug benefits by medicare beneficiaries. JAMA Int Med. 2013;1–8. Kuye IO, Frank RG, McWilliams JM. Cognition and take-up of subsidized drug benefits by medicare beneficiaries take-up of drug benefits by medicare beneficiaries. JAMA Int Med. 2013;1–8.
12.
go back to reference Chan S, Elbel B. Low cognitive ability and poor skill with numbers may prevent many from enrolling in Medicare supplemental coverage. Health Aff. 2012;31(8):1847–1854.CrossRef Chan S, Elbel B. Low cognitive ability and poor skill with numbers may prevent many from enrolling in Medicare supplemental coverage. Health Aff. 2012;31(8):1847–1854.CrossRef
13.
go back to reference Hanoch Y, Wood S, Barnes A, Liu PJ, Rice T. Choosing the right medicare prescription drug plan: the effect of age, strategy selection, and choice set size. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2011;30(6):719–727. Hanoch Y, Wood S, Barnes A, Liu PJ, Rice T. Choosing the right medicare prescription drug plan: the effect of age, strategy selection, and choice set size. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2011;30(6):719–727.
14.
go back to reference Wood S, Hanoch Y, Barnes A, et al. Numeracy and Medicare Part D: the importance of choice and literacy for numbers in optimizing decision making for Medicare’s prescription drug program. Psychol Aging. 2011;26(2):295–307.CrossRefPubMed Wood S, Hanoch Y, Barnes A, et al. Numeracy and Medicare Part D: the importance of choice and literacy for numbers in optimizing decision making for Medicare’s prescription drug program. Psychol Aging. 2011;26(2):295–307.CrossRefPubMed
15.
go back to reference Bundorf MK, Szrek H. Choice set size and decision making: the case of Medicare Part D prescription drug plans. Medical Decis Making Int J Soc Med Decis Making. 2010;30(5):582–593.CrossRef Bundorf MK, Szrek H. Choice set size and decision making: the case of Medicare Part D prescription drug plans. Medical Decis Making Int J Soc Med Decis Making. 2010;30(5):582–593.CrossRef
16.
go back to reference Scanlon DP, Chernew M, Lave JR. Consumer health plan choice: current knowledge and future directions. Annu Rev Public Health. 1997;18:507–528.CrossRefPubMed Scanlon DP, Chernew M, Lave JR. Consumer health plan choice: current knowledge and future directions. Annu Rev Public Health. 1997;18:507–528.CrossRefPubMed
17.
go back to reference Reid RO, Deb P, Howell BL, Shrank WH. Association between medicare advantage plan star ratings and enrollment. JAMA. 2013;309(3):267–274.CrossRefPubMed Reid RO, Deb P, Howell BL, Shrank WH. Association between medicare advantage plan star ratings and enrollment. JAMA. 2013;309(3):267–274.CrossRefPubMed
21.
go back to reference Eicheldinger C, Bonito A. More accurate racial and ethnic codes for Medicare administrative data. Health Care Financing Rev. 2008;29(3):27–42. Eicheldinger C, Bonito A. More accurate racial and ethnic codes for Medicare administrative data. Health Care Financing Rev. 2008;29(3):27–42.
22.
go back to reference Atherly A, Dowd BE, Feldman R. The effect of benefits, premiums, and health risk on health plan choice in the Medicare program. Health Serv Res. 2004;39(4 Pt 1):847–864.PubMedCentralCrossRefPubMed Atherly A, Dowd BE, Feldman R. The effect of benefits, premiums, and health risk on health plan choice in the Medicare program. Health Serv Res. 2004;39(4 Pt 1):847–864.PubMedCentralCrossRefPubMed
23.
go back to reference Edgman-Levitan S, Cleary PD. What information do consumers want and need? Health Aff. 1996;15(4):42–56.CrossRef Edgman-Levitan S, Cleary PD. What information do consumers want and need? Health Aff. 1996;15(4):42–56.CrossRef
25.
go back to reference Mechanic D. Consumer choice among health insurance options. Health Aff. 1989;8(1):138–148.CrossRef Mechanic D. Consumer choice among health insurance options. Health Aff. 1989;8(1):138–148.CrossRef
26.
go back to reference Harris KM. Can high quality overcome consumer resistance to restricted provider access? Evidence from a health plan choice experiment. Health Serv Res. 2002;37(3):551–571.PubMedCentralCrossRefPubMed Harris KM. Can high quality overcome consumer resistance to restricted provider access? Evidence from a health plan choice experiment. Health Serv Res. 2002;37(3):551–571.PubMedCentralCrossRefPubMed
27.
go back to reference Xu P, Burgess JJF, Cabral H, Soria-Saucedo R, Kazis LE. Relationships between medicare advantage contract characteristics and quality-of-care ratings an observational analysis of medicare advantage star ratings contract characteristics and the delivery of quality of care. Ann Intern Med. 2015;162(5):353–358.CrossRefPubMed Xu P, Burgess JJF, Cabral H, Soria-Saucedo R, Kazis LE. Relationships between medicare advantage contract characteristics and quality-of-care ratings an observational analysis of medicare advantage star ratings contract characteristics and the delivery of quality of care. Ann Intern Med. 2015;162(5):353–358.CrossRefPubMed
28.
go back to reference Weinick R, Haviland A, Hambarsoomian K, Elliott MN. Does the racial/ethnic composition of medicare advantage plans reflect their areas of operation? Health Serv Res. 2014;49(2):526–545.PubMedCentralCrossRefPubMed Weinick R, Haviland A, Hambarsoomian K, Elliott MN. Does the racial/ethnic composition of medicare advantage plans reflect their areas of operation? Health Serv Res. 2014;49(2):526–545.PubMedCentralCrossRefPubMed
31.
go back to reference Hibbard JH, Stockard J, Tusler M. Does Publicizing Hospital Performance Stimulate Quality Improvement Efforts? Health Aff. 2003;22(2):84–94.CrossRef Hibbard JH, Stockard J, Tusler M. Does Publicizing Hospital Performance Stimulate Quality Improvement Efforts? Health Aff. 2003;22(2):84–94.CrossRef
32.
go back to reference Mehrotra A, Hussey PS, Milstein A, Hibbard JH. Consumers’ and providers’ responses to public cost reports, and how to raise the likelihood of achieving desired results. Health Aff. 2012;31(4):843–851.CrossRef Mehrotra A, Hussey PS, Milstein A, Hibbard JH. Consumers’ and providers’ responses to public cost reports, and how to raise the likelihood of achieving desired results. Health Aff. 2012;31(4):843–851.CrossRef
33.
go back to reference Gold M. Medicare Advantage—lessons for Medicare’s future. N Engl J Med. 2012;366(13):1174–1177. Gold M. Medicare Advantage—lessons for Medicare’s future. N Engl J Med. 2012;366(13):1174–1177.
Metadata
Title
The Roles of Cost and Quality Information in Medicare Advantage Plan Enrollment Decisions: an Observational Study
Authors
Rachel O. Reid, MD, MS
Partha Deb, PhD
Benjamin L. Howell, PhD
Patrick H. Conway, MD, MSc
William H. Shrank, MD, MSHS
Publication date
01-02-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3467-3

Other articles of this Issue 2/2016

Journal of General Internal Medicine 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine